M&A Deal Summary

Great Point Partners Acquires Cellipont Bioservices

On January 11, 2022, private equity firm Great Point Partners acquired life science company Cellipont Bioservices

Acquisition Highlights
  • This is Great Point Partners’ 12th transaction in the Life Science sector.
  • This is Great Point Partners’ 24th transaction in the United States.
  • This is Great Point Partners’ 4th transaction in Texas.

M&A Deal Summary
Date 2022-01-11
Target Cellipont Bioservices
Sector Life Science
Buyer(s) Great Point Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Cellipont Bioservices

The Woodlands, Texas, United States
Cellipont Bioservices is a contract and development manufacturing organization (“CDMO”) of cell therapy products for biopharmaceutical companies. The company leverages its world-class expertise in cell manufacturing and master cell banks, regulatory track record, and technical expertise to maintain a leading position as a global CDMO focused on cell therapy. Cellipont Bioservices was formed in 2002 and is based in The Woodlands, Texas.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Great Point Partners

Greenwich, Connecticut, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2003
PE ASSETS 1.7B USD
Size Large
Type Sector Focused
DESCRIPTION

Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $10 to $100 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 30 of 35
Sector (Life Science) 12 of 14
Type (Buyout (LBO, MBO, MBI)) 8 of 9
State (Texas) 4 of 4
Country (United States) 24 of 28
Year (2022) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-01 E-Therapy

Flagstaff, Arizona, United States

E-Therapy is a provider of speech-language pathology and mental health services via telehealth in K-12 schools. It provides care across four service lines: speech therapy, occupational therapy, physical therapy, and mental health. E-Therapy was formed in 2009 and is based in Flagstaff, Arizona.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-04 JPA Health

Washington, District of Columbia, United States

JPA Health is an independent, full-service agency that provides marketing, public relations, and advocacy services. The company works with many healthcare companies, NGOs, and federal government agencies. JPA Health was formed in 2007 and is based in Washington, District of Columbia.

Buy -
Mergr

Product

Company

Legal